Sanofi

Multinational Pharma Share Declines in Indian Drug Market. (Image Source: Freepik)

Pharma MNCs continue to lose India market share

The presence of multinational pharma companies (MNCs) in India’s drug market continues to shrink, reaching 14.5% in May 2025 from…

June 8, 2025 18:27 IST

dividend stocks, stock split, April 2025 corporate actions, CRISIL dividend,

Upcoming dividend announcement, stock split this week: Watch out for these 5 stocks

Watch for dividends, stock splits from CRISIL, Hexaware, Kapil Raj, and more this week. Hold stocks before ex-dates for payouts.

Updated: April 14, 2025 15:04 IST

USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months

Qfitlia does not replace the missing clotting factor. Rather, it reduces the amount of a protein called antithrombin, leading to…

March 30, 2025 11:43 IST

Sanofi to increase competition in atopic dermatitis market after Dupixent’s success

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition in atopic dermatitis treatment.

January 19, 2025 15:41 IST

Sanofi’s Multiple sclerosis drug misses goal in trials for relapsing disease forms

On Monday, Sanofi only provided a brief summary of the trials, holding off details for a medical conference in Copenhagen…

September 2, 2024 16:28 IST

Sanofi resets footprint in India, Hyd GCC to add new digital competencies

On the investments made, a note shared by the company said, there were plans to invest in all €400 million…

July 17, 2024 17:34 IST

French drugmaker Sanofi to invest over €1 billion in production sites

Sanofi to expand its Global Capacity Centre in Hyderabad

The Hyderabad hub has grown exponentially from being a Medical Hub to now providing several best-in-class services to Sanofi’s global…

July 17, 2024 16:40 IST

Rare diseases, rare diseases in India, Sanofi, Sanofi India, sanofi specialty care, healthcare news, pharma news,

We are moving into newer disease areas; Xenpozyme will be launched in India soon: Anil Raina, GM, Sanofi Specialty Care, India

The French drugmakers have launched groundbreaking medicines for Gaucher disease, Pompe disease, Fabry disease, mucopolysaccharidosis I (MPS I) and acid…

May 30, 2024 16:07 IST

French drugmaker Sanofi to invest over €1 billion in production sites

Sanofi will invest an additional €700 million per year in R&D over the next two years. In 2023, Sanofi invested…

May 14, 2024 10:58 IST

Sanofi launches its anti-diabetic drug in India—Know cost and other key details

According to the company, Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting…

May 1, 2024 11:01 IST

Sanofi’s new polio vaccine gets nod in India amid speculations of potential shortage

Sanofi and Serum Institute of India are the leading suppliers of IPV vaccines in India.

April 8, 2024 11:12 IST

French drugmaker Sanofi agrees to settle 4,000 Zantac cancer lawsuits in US state courts

Sanofi now sells Zantac360, a reformulated heartburn medicine whose active ingredient is famotidine.

April 4, 2024 12:38 IST

Sanofi India and Cipla's shares rose today

Sanofi to launch key drugs from its global pipeline in India soon

The company is also looking at widening access through partnerships with companies like Cipla, Dr Reddy’s Laboratories, and Emcure.

April 2, 2024 10:42 IST

Dr Reddy’s to distribute Sanofi’s paediatric and adult vaccine brands in India

The partnership with Sanofi gives Dr. Reddy’s a strong portfolio and major presence in the vaccine segment taking it to…

March 27, 2024 17:59 IST

Sanofi India, Cipla, partnership, distribution, CNS portfolio, anti-epileptic medication, production, manufacturing, healthcare

Sanofi, Cipla enters into exclusive distribution partnership to expand reach of CNS portfolio in India

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India…

March 27, 2024 09:33 IST

Sanofi, rare disease portfolio, sanofi product portfolio, healthcare news, pharma news,

Sanofi drops rare disease drug purchase after FTC files suit

Sanofi owns the only FDA approved treatments — a biweekly infusion — but Maze is developing a daily oral medication…

December 12, 2023 16:47 IST

Sanofi taps adviser for OTC spinoff as buyout firms circle

The business has also attracted some initial interest from major buyout firms that have been evaluating a potential acquisition

November 16, 2023 15:02 IST

Sanofi spinoff EuroAPI’s shares plunge on sales surprise

Sanofi still owns 30% of EuroAPI and the French state has a 12% stake, reflecting government efforts to bolster national…

October 10, 2023 16:24 IST

Related News

e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more

Govt breaks silence on 8th Pay Commission implementation date; Finance Ministry confirms ‘fund provision’

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

Canada work permit, Canada Temporary Foreign Worker Program, Canada TFWP Rules, Canada LMIA process, LMIA process

Canada drops wage assessment under TFWP; Work permits now based on LMIA

H-1B visas, US Visa, F-1 visa, Indian students in US, Indian workers in US, Ministry of External Affairs

US tightens F-1 and H-1B visa rules; questions raised in parliament: MEA responds

Trump approves Nvidia H200 shipments to China, says ‘will protect national security’

World News46 min ago

The US government has approved the export of Nvidia’s AI chips to China with a 25% fee per chip. This decision comes after a debate on national security concerns. President Trump announced the move on Truth Social and informed President Xi Jinping, who responded positively.

View all shorts